12/15-lipoxygenase orchestrates murine wound healing via PPARγ-activating oxylipins acting holistically to dampen inflammation
Abstract
12/15-lipoxygenase (12/15-LOX, Alox15 ) generates bioactive oxygenated lipids during inflammation, however its homeostatic role(s) in normal healing are unclear. Here, the role of 12/15-LOX in resolving skin wounds was elucidated, focusing on how its lipids act together in physiologically relevant amounts. In mice, wounding caused acute appearance of 12/15-LOX-expressing macrophages and stem cells, coupled to early generation of ~12 monohydroxy-oxylipins and enzymatically oxidized phospholipids (eoxPL). Alox15 deletion increased collagen deposition, stem cell/fibroblast proliferation, IL6/pSTAT3, pSMAD3, and interferon (IFN)-γ levels. Conversely, CD206 expression, F480+ cells, and MMP9 and MMP2 activities were reduced. Alox15 −/− skin was deficient in PPARγ/adiponectin activity. Furthermore, while pro-inflammatory genes were upregulated as normal during wounding, many including Il6, Il1b, ccl4, Cd14, Cd274, Clec4d, Clec4e, Csf3, Cxcl2, and miR-21 failed to revert to baseline during healing, indicating disruption of PPARγ’s anti-inflammatory brake on NLRP3/inflammasome and TGF-β signaling. Reconstituting Alox15 −/− wounds with a physiological mixture of Alox15 -derived primary oxylipins generated by healing wounds restored MMP and dampened collagen deposition. The oxylipin mixture activated the PPARγ response element in vitro, while in vivo, its coactivator, Helz2 , was significantly upregulated as well as several fatty acid and prostaglandin PPARγ ligands. Additional inflammatory and proliferative gene networks impacted by Alox15 −/− included Elf4, Cebpb , and Tcf3. In summary, 12/15-LOX generates abundant monohydroxy oxylipins that act together via PPARγ. The identification of multiple gene alterations reveals several targets for treating nonhealing wounds. Our studies demonstrate that 12/15-LOX oxylipins act in concert, dampening inflammation in vivo, revealing the need to consider lipid signaling holistically.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (20)
Christopher P. Thomas
School of Pharmacy and Pharmaceutical Sciences, Cardiff University
Victoria J. Tyrrell
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
James J. Burston
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Sam R. C. Johnson
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Maceler Aldrovandi
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Jorge Alvarez-Jarreta
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Rossa Inglis
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Adam Leonard
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Lydia Fice
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Jeremie Costales
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Antonio Vidal-Puig
Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)
Majd Protty
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Carol Guy
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Robert Andrews
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Barbara Szomolay
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Ben C. Cossins
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Ana Cardus Figueras
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Stefania Carobbio
Centro de Investigacion Principe Felipe, Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM)
Simon A. Jones
Systems Immunity Research Institute and Division of Infection and Immunity, School of Medicine, Cardiff University
Valerie B. O’Donnell